SEC Comment Letter 0000000000-24-004075 to zSpace, Inc. (ZSPC)
zSpace, Inc.
Date: April 16, 2024 · CIK: 0001637147 · Accession: 0000000000-24-004075
AI Filing Summary & Sentiment
Show Raw Text
United States securities and exchange commission logo
April 15, 2024
Paul Kellenberger
Chief Executive Officer
zSpace, Inc.
65 Nicholson Lane
San Jose, CA 95134
Re:zSpace, Inc.
Amendment No. 2 to Draft Registration Statement on Form S-1
Submitted April 1, 2024
CIK No. 0001637147
Dear Paul Kellenberger:
We have reviewed your amended draft registration statement and have the following
comments.
Please respond to this letter by providing the requested information and either submitting
an amended draft registration statement or publicly filing your registration statement on
EDGAR. If you do not believe a comment applies to your facts and circumstances or do not
believe an amendment is appropriate, please tell us why in your response.
After reviewing the information you provide in response to this letter and your amended
draft registration statement or filed registration statement, we may have additional
comments. Unless we note otherwise, any references to prior comments are to comments in our
March 11, 2024 letter.
Amendment No. 2 to Draft Registration Statement on Form S-1 submitted April 1, 2024
Capitalization, page 51
1.We note your response to prior comment 10. Please revise to include an adjustment to
eliminate the interest expense and debt discount amortization on loans that were converted
into NCNV preferred stock as part of the recapitalization transaction. Include similar
adjustments to the pro forma consolidated balance sheet data on page 12.
Dilution, page 54
2.We note your response to prior comment 11. As previously requested, please revise to
exclude deferred offering costs from net tangible book value and net tangible book
value per share.
FirstName LastNamePaul Kellenberger
Comapany NamezSpace, Inc.
April 15, 2024 Page 2
FirstName LastName
Paul Kellenberger
zSpace, Inc.
April 15, 2024
Page 2
Management's Discussion and Analysis of Financial Condition and Results of Operations
Non-GAAP Financial Measures, page 60
3.Your response to prior comment 12 indicates that the inventory adjustments in 2022
related to inventory write-offs associated with product and component shortages due to
pandemic-related supply chain disruptions, which you do not expect to recur; however, it
appears that there will be similar inventory adjustments in 2023. As inventory write-offs
are a normal, recurring operating expense necessary to operate your business these
adjustments are inconsistent with Question 100.01 of the Non-GAAP C&DIs. Please
revise your non-GAAP measures to remove these adjustments.
Consolidated Financial Statements
Note 7. Stock-based Compensation Expense
Determination of fair value of stock options, page F-27
4.We note your responses to prior comments 20 and 21 and your revised disclosures. Please
tell us how you considered ASC 718-10-30-27 when determining your accounting. In this
regard, we note that when you determined the expected term of the stock options with a
performance condition, you considered the contractual date of the performance condition
and that the volatility was determined over the estimated time to the liquidity event. ASC
718-10-30-27 indicates that performance conditions which affect vesting should not be
reflected in estimating the fair value of an award at the grant date. Please revise your
disclosures and the valuations of any stock options containing performance conditions
accordingly. Also, as previously requested in prior comment 20, tell us the fair value of
the underlying common stock for the options granted in 2022.
September 2022 Stock Option Issuance, page F-28
5.You disclose on page F-29 that you will begin recognizing expense related to the
September 2022 options upon the occurrence of a liquidity event and it appears that this
offering is a liquidity event. Please revise to disclose the amount of expense you will
record upon effectiveness of the offering.
Please contact Dave Edgar at 202-551-3459 or Chris Dietz at 202-551-3408 if you have
questions regarding comments on the financial statements and related matters. Please contact
Uwem Bassey at 202-551-3433 or Jan Woo at 202-551-3453 with any other questions.
Sincerely,
Division of Corporation Finance
Office of Technology
cc: Evan Mendelsohn